Film About a Fictional Trial of an Aging Therapy Named Among 65 Future Vision XPRIZE Selections

Film About a Fictional Trial of an Aging Therapy Named Among 65 Future Vision XPRIZE Selections

On September 3, Future Vision XPRIZE, a science fiction film competition focused on an optimistic technological future, named director Tim Maupin’s short film The Last Generation to Die among its 65 selected entries. The story follows a family whose members fall on opposite sides of the eligibility rules for a clinical trial.

The Last Generation to Die is set in the near future. A scientist named Lily is working on a technology that slows and reverses aging. Her father, Oliver, has severe heart disease and is accepted into the trial. As his biological age is reversed, his health improves.

When Lily’s mother develops a rare neurodegenerative disease, which progressively damages the nervous system, the trial’s eligibility criteria exclude her. These rules determine who can participate. The family watches the father’s condition improve as the mother’s condition worsens. In an interview, Maupin says that he returned to the screenplay after his father died in 2019.

The story also follows company employees who want to extract as much profit as possible from the technology, while Lily tries to stop them. This corporate conflict adds a dispute over how the technology will be distributed to the question of who qualifies for the trial.

Maupin describes this transition as follows:

“There will come a point when some people, unfortunately, will not make it in time, while others will gain access to age-reversal technologies.”